Let’s start up with the current stock price of Dare Bioscience Inc. (DARE), which is $1.54 to be very precise. The Stock rose vividly during the last session to $1.62 after opening rate of $1.36 while the lowest price it went was recorded $1.36 before closing at $1.36.
Recently in News on January 5, 2021, Daré Bioscience to Participate in Fireside Chat at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference. Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that Sabrina Martucci Johnson, its President and Chief Executive Officer, will participate in a fireside chat at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference to be held January 11-14, 2021. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Dare Bioscience Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $1.6200 on 01/14/21, with the lowest value was $1.2700 for the same time period, recorded on 01/13/21.
Dare Bioscience Inc. (DARE) full year performance was -0.87%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Dare Bioscience Inc. shares are logging -13.48% during the 52-week period from high price, and 105.33% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.75 and $1.78.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 3489892 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Dare Bioscience Inc. (DARE) recorded performance in the market was 14.93%, having the revenues showcasing 43.93% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 58.92M, as it employees total of 15 workers.
Market experts do have their say about Dare Bioscience Inc. (DARE)
During the last month, 5 analysts gave the Dare Bioscience Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.1541, with a change in the price was noted +0.4000. In a similar fashion, Dare Bioscience Inc. posted a movement of +35.09% for the period of last 100 days, recording 874,061 in trading volumes.
Technical breakdown of Dare Bioscience Inc. (DARE)
Raw Stochastic average of Dare Bioscience Inc. in the period of last 50 days is set at 87.65%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 84.00%. In the last 20 days, the company’s Stochastic %K was 70.13% and its Stochastic %D was recorded 65.36%.
Bearing in mind the latest performance of Dare Bioscience Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 14.93%. Additionally, trading for the stock in the period of the last six months notably improved by 20.31%, alongside a downfall of -0.87% for the period of the last 12 months. The shares increased approximately by 10.79% in the 7-day charts and went down by 33.91% in the period of the last 30 days. Common stock shares were driven by 43.93% during last recorded quarter.